Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ATP13A2 anticorps (AA 1001-1080) (Cy7)

ATP13A2 Reactivité: Rat IF (cc), IF (p) Hôte: Lapin Polyclonal Cy7
N° du produit ABIN1410762
  • Antigène Voir toutes ATP13A2 Anticorps
    ATP13A2 (ATPase Type 13A2 (ATP13A2))
    Épitope
    • 14
    • 8
    • 7
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 1001-1080
    Reactivité
    • 23
    • 16
    • 2
    • 1
    Rat
    Hôte
    • 34
    • 3
    Lapin
    Clonalité
    • 35
    • 2
    Polyclonal
    Conjugué
    • 13
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ATP13A2 est conjugé à/à la Cy7
    Application
    • 19
    • 19
    • 12
    • 12
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
     Réactivité croisée
    Rat
    Homologie
    Human,Mouse,Cow,Pig,Horse,Rabbit
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human ATP13A2
    Isotype
    IgG
    Top Product
    Discover our top product ATP13A2 Anticorps primaire
  • Indications d'application
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    ATP13A2 (ATPase Type 13A2 (ATP13A2))
    Autre désignation
    PARK9/ATP13A2 (ATP13A2 Produits)
    Synonymes
    anticorps ATP13A2, anticorps 1110012E06Rik, anticorps AA589443, anticorps RGD1307977, anticorps im:7147302, anticorps zgc:136762, anticorps CLN12, anticorps HSA9947, anticorps KRPPD, anticorps PARK9, anticorps ATPase 13A2, anticorps ATPase type 13A2, anticorps probable cation-transporting ATPase 13A2, anticorps ATP13A2, anticorps Atp13a2, anticorps atp13a2, anticorps PTRG_01071, anticorps MCYG_01937, anticorps LOC100439053
    Sujet

    Synonyms: AT132_HUMAN, Atp13a2, ATPase type 13A2, CLN12, HSA9947, KRPPD, PARK9, Probable cation transporting ATPase 13A2, Probable cation-transporting ATPase 13A2, Putative ATPase, RP1-37C10.4.

    Background: ATP13A2 is a 1,180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations. Expressed as multiple alternative spliced isoforms, ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, thereby participating in the active transport of ions across cellular membranes. Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), a rare hereditary type of Parkinson?s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia. The ATP13A2 gene maps to human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8 % of the human genome.

    Pathways
    Ribonucleoside Biosynthetic Process
Vous êtes ici:
Support technique